Jason Baum's most recent trade in Cypherpunk Technologies Inc. was a trade of 22,500 Common Stock done . Disclosure was reported to the exchange on March 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | Jason Baum | Chief Scientific Officer | 28 Mar 2025 | 22,500 | 22,500 (0%) | 0% | - | Common Stock | ||
| Leap Therapeutics Inc | Jason Baum | Chief Scientific Officer | 28 Mar 2025 | 22,500 | 0 | - | - | Restricted Stock Units | ||
| Leap Therapeutics Inc | Jason Baum | Chief Scientific Officer | 28 Mar 2025 | 6,604 | 15,896 (0%) | 0% | 0.3 | 2,091 | Common Stock | |
| Leap Therapeutics Inc | Jason Baum | Chief Scientific Officer | 02 Oct 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Leap Therapeutics Inc | Jason Baum | Chief Scientific Officer | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Leap Therapeutics Inc | Jason Baum | Chief Scientific Officer | 23 Aug 2023 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) |